Evommune EVMN
NYSE EVMN
$8.31 -0.08 (-0.95%)
As of: Sep 29, 2026 · 3:59 PM EDT

Evommune (EVMN) Current Assets (2024 - 2026)

Updated

Evommune (EVMN) posted Current Assets of $204.25 million for Q2 2026, down 5.4% from the prior quarter.

Analysis

Evommune (EVMN) Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Evommune's Current Assets came in at $153.48 million, up 107.4% from FY2024.

  • In prior years, Evommune's Current Assets was $73.99 million in FY2024.
  • Quarterly Current Assets has run from a low of $73.99 million in Q4 2024 to a high of $215.86 million in Q1 2026 over five years.
  • According to Business Quant data, Current Assets for the three prior quarters was $215.86 million (Q1 2026), $153.48 million (Q4 2025) and $81.94 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 59.77 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 33.67 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 36.68 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 27.35 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 27.97 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.96 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 13.95 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 41.36 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 12.54 Bn
10 Evommune 304.40 Mn -333.11 Mn - 204.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 204.25 Mn
Mar 31, 2026 215.86 Mn
Dec 31, 2025 153.48 Mn
Sep 30, 2025 81.94 Mn
Dec 31, 2024 73.99 Mn
API Access

Evommune Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=EVMN&period=max&api_key=YOUR_API_KEY